HOXB7 Antikörper (AA 55-120)
-
- Target Alle HOXB7 Antikörper anzeigen
- HOXB7 (Homeobox B7 (HOXB7))
-
Bindungsspezifität
- AA 55-120
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HOXB7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant HOXB7.
- Sequenz
- MQGLYPGGGG MAGQSAAGVY AAGYGLEPSS FNMHCAPFEQ NLSGVCPGDS AKAAGAKEQR DSDLAA
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- HOXB7 (NP_004493, 55 a.a. ~ 120 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 4C6
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo." in: PLoS ONE, Vol. 10, Issue 6, pp. e0130551, (2015) (PubMed).
: "A novel predictive equation for potential diagnosis of cholangiocarcinoma." in: PLoS ONE, Vol. 9, Issue 2, pp. e89337, (2014) (PubMed).
: "
-
Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo." in: PLoS ONE, Vol. 10, Issue 6, pp. e0130551, (2015) (PubMed).
-
- Target
- HOXB7 (Homeobox B7 (HOXB7))
- Andere Bezeichnung
- HOXB7 (HOXB7 Produkte)
- Hintergrund
-
Full Gene Name: homeobox B7
Synonyms: HHO.C1,HOX2,HOX2C,Hox-2.3 - Gen-ID
- 3217
- NCBI Accession
- NM_004502
-